CRBU - Caribou Biosciences Inc
IEX Last Trade
2.165
0.055 2.540%
Share volume: 569,309
Last Updated: Fri 30 Aug 2024 09:59:46 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.11
0.06
2.61%
Summary score
9%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
2%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.3%
Return on assets
-7.53%
Return on sales
-873.83%
Return on invested capital
-44.36%
Total debt ratio
17.61%
Debt ratio change over timeo
-1.48%
Current Ratio
11.04%
Quick Ratio
11.04%
Cash Position Ratio
10.61%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.75%
Return on assets
-8.14%
Return on sales
-970.84%
Return on invested capital
-46.37%
Total debt ratio
16.57%
Debt ratio change over timeo
-1.5%
Current Ratio
11.14%
Quick Ratio
11.14%
Cash Position Ratio
10.77%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-12.01%
Return on assets
-11.31%
Return on sales
-1893.87%
Return on invested capital
-56.26%
Total debt ratio
15.62%
Debt ratio change over time
-1.29%
Current Ratio
10.49%
Quick Ratio
10.49%
Cash Position Ratio
10.13%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-79.82%
Return on assets
-81.1%
Return on sales
1844.74%
Return on invested capital
4.09%
Total debt ratio
-148.38%
Debt ratio change over time
-1.48%
Current Ratio
-34.95%
Quick Ratio
-34.95%
Cash Position Ratio
-33.66%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRBU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.3% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.53% | 2.76% | 3.15% | 5.62% |
| Return on sales | -873.83% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -44.36% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 17.61% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.48% | 308.97% | -6.99% | 1.18% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 11.14% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 10.77% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 10% | 23% |
| Short-term ratios | CRBU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.75% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.14% | 2.43% | 1.89% | 3.09% |
| Return on sales | -970.84% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -46.37% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 16.57% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.5% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 11.14% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 10.77% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 29% |